Xu Wang

Also affiliated with Wangjing Hospital of China Academy of Chinese Medical Sciences, China Academy of Chinese Medical Sciences, First Affiliated Hospital of Henan University, Institute of New Materials

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG”.

Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2131416

N/A

0DataRank · unranked

0 citations

Ian Thomas, Xu Wang, Cono Ariti, Priyanka Mehta, Mia Sydenham +11 more